Cargando…
(177)Lu-labelled macrocyclic bisphosphonates for targeting bone metastasis in cancer treatment
BACKGROUND: Metastatic bone lesion is a common syndrome of many cancer diseases in an advanced state. The major symptom is severe pain, spinal cord compression, and pathological fracture, associated with an obvious morbidity. Common treatments including systemic application of bisphosphonate drugs a...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715021/ https://www.ncbi.nlm.nih.gov/pubmed/26780082 http://dx.doi.org/10.1186/s13550-016-0161-3 |